Ibogaine

This document provides a concise overview of ibogaine, a psychoactive alkaloid derived from the Tabernanthe iboga shrub native to Central Africa, and its potential use in treating opioid dependence. It explains ibogaine's pharmacology, including its effects on multiple neurotransmitter systems and its ability to reduce opioid withdrawal symptoms. The document traces ibogaine's development history, from its early medical use in France to its current legal status, which varies globally from banned to prescription-only. It highlights key research milestones, including anecdotal evidence and limited clinical studies, and notes ongoing interest in ibogaine-assisted detoxification amid the opioid crisis. The legal and regulatory landscape is discussed, emphasizing the need for medical oversight due to safety concerns.

Click HERE to DOWNLOAD for FREE